Product
Dorzolamide-timolol-brimonidine and latanoprost
Aliases
Gaap Ofteno PF®, Krytantek Ofteno PF®, PRO-122
1 clinical trial
3 indications
Indication
GlaucomaIndication
Open-AngleIndication
ocular hypertensionClinical trial
Phase IV Clinical Study to Compare the Efficacy of the Krytantek Ofteno PF® Plus Gaap Ofteno PF® Combination to the Krytantek Ofteno PF® Plus Gaap Ofteno PF® Combination, in Primary Open Angle Glaucoma or Ocular Hypertension Patients.Status: Terminated, Estimated PCD: 2023-11-23